Search Results 331-340 of 18314 for Primary hyperparathyroidism
... Hyperparathyroidism, Graves' disease, Primary aldosteronism, MEN 2B, Zollinger Ellison Syndrome, Aldosteronoma, Multinodular goiter, Tertiary ...
... Hyperparathyroidism, Graves' disease, Primary aldosteronism, MEN 2B, Aldosteronoma, Multinodular goiter, Tertiary hyperparathyroidism, Parathyroid disease ...
Underlying disease that significantly impacts bone metabolism such as primary hyperparathyroidism, hyperthyroidism, paget's disase of bone, fibrous dyplasia, or ...
... Hyperparathyroidism, Thyroid cancer, Cushing syndrome, Graves' disease ... Primary hyperparathyroidism, Secondary hyperparathyroidism, Pediatric ...
Mayo Clinic was one of the first centers to study ursodeoxycholic acid (UDCA) as a treatment option. Researchers are currently studying new medications — ...
... disease, Hyperparathyroidism, Pediatric parathyroid disorder, Pheochromocytoma, Adrenal cancer, Primary aldosteronism, Zollinger Ellison Syndrome, Primary ...
... Hyperparathyroidism, Thyroid cancer, Cushing syndrome, Graves' disease ... Primary hyperparathyroidism, Pediatric endocrine disorder, Pediatric adrenal ...
The primary objective of the United States Food and Drug Administration (FDA) for this study is to demonstrate non-inferiority in subjects who received an ...
... hyperparathyroidism, Primary hyperparathyroidism, Adrenal insufficiency, Metabolic bone disease, Osteomalacia, Hypophosphatemia. Show more areas of focus for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.